Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement

Description

The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-associated heart failure (MAHF) and linkage to evidence-based cardiology care for people who use methamphetamine in rural areas.

Conditions

Methamphetamine Use, Heart Failure

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-associated heart failure (MAHF) and linkage to evidence-based cardiology care for people who use methamphetamine in rural areas.

Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement

Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement

Condition
Methamphetamine Use
Intervention / Treatment

-

Contacts and Locations

Portland

Oregon Health & Science University, Portland, Oregon, United States, 97239

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patient-defined regular use of methamphetamine in the last year
  • * Any methamphetamine use in the past 30 days
  • * Age 18 years or older
  • * No client-reported diagnosis of heart failure
  • * Able to communicate in English
  • * Screen positive for potential methamphetamine-associated heart failure (MAHF) defined as B type natriuretic peptide (BNP) ≥50 pg/ml, or QRS width ≥120ms, or presence of any clinical heart failure symptoms
  • * Self-reported engagement in medical care for heart failure in past 6 months.
  • * Actively taking medications for heart failure.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Oregon Health and Science University,

Brian Chan, MD, MPH, PRINCIPAL_INVESTIGATOR, Oregon Health and Science University

Study Record Dates

2029-06-30